Miyakogusa Predicted Gene
- Lj5g3v0540160.1
BLASTP 2.2.25 [Feb-01-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= Lj5g3v0540160.1 Non Chatacterized Hit- tr|B9SMW1|B9SMW1_RICCO
ATP-binding cassette transporter, putative OS=Ricinus
,21.58,0.000005,seg,NULL; no description,NULL; ATP-BINDING CASSETTE
TRANSPORTER (PDR),NULL; ATP-BINDING CASSETTE TRA,gene.g59222.t1.1
(505 letters)
Database: TAIR10_pep
35,386 sequences; 14,482,855 total letters
Searching..................................................done
Score E
Sequences producing significant alignments: (bits) Value
AT1G15520.1 | Symbols: PDR12, ATPDR12, ABCG40, ATABCG40 | pleiot... 311 7e-85
AT1G66950.1 | Symbols: PDR11, ATPDR11 | pleiotropic drug resista... 287 1e-77
AT2G36380.1 | Symbols: PDR6, ATPDR6 | pleiotropic drug resistanc... 283 2e-76
AT3G16340.2 | Symbols: PDR1 | pleiotropic drug resistance 1 | ch... 264 8e-71
AT1G59870.1 | Symbols: PEN3, PDR8, ATPDR8, ABCG36, ATABCG36 | AB... 263 2e-70
AT2G26910.1 | Symbols: PDR4, ATPDR4 | pleiotropic drug resistanc... 259 3e-69
AT3G16340.1 | Symbols: ATPDR1, PDR1 | pleiotropic drug resistanc... 258 6e-69
AT1G15210.1 | Symbols: PDR7, ATPDR7 | pleiotropic drug resistanc... 258 6e-69
AT4G15215.1 | Symbols: PDR13, ATPDR13 | pleiotropic drug resista... 258 7e-69
AT3G30842.1 | Symbols: PDR10, ATPDR10 | pleiotropic drug resista... 243 2e-64
AT2G37280.1 | Symbols: PDR5, ATPDR5 | pleiotropic drug resistanc... 242 4e-64
AT3G53480.1 | Symbols: PIS1, PDR9, ATPDR9, ABCG37 | pleiotropic ... 238 9e-63
AT2G29940.1 | Symbols: PDR3, ATPDR3 | pleiotropic drug resistanc... 229 5e-60
AT4G15230.1 | Symbols: ATPDR2, PDR2 | pleiotropic drug resistanc... 220 2e-57
AT4G15236.1 | Symbols: | ABC-2 and Plant PDR ABC-type transport... 220 2e-57
AT4G15233.1 | Symbols: | ABC-2 and Plant PDR ABC-type transport... 215 6e-56
AT4G15233.2 | Symbols: | ABC-2 and Plant PDR ABC-type transport... 215 7e-56
>AT1G15520.1 | Symbols: PDR12, ATPDR12, ABCG40, ATABCG40 |
pleiotropic drug resistance 12 | chr1:5331993-5338175
REVERSE LENGTH=1423
Length = 1423
Score = 311 bits (797), Expect = 7e-85, Method: Compositional matrix adjust.
Identities = 152/281 (54%), Positives = 187/281 (66%), Gaps = 45/281 (16%)
Query: 214 DGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTVK 273
+G I+Y+GPR++V+EFFE+MGFKCP RKGVADFLQEVTS+KDQ QYWA +DEPYRF+ V+
Sbjct: 402 EGEIIYEGPRDHVVEFFETMGFKCPPRKGVADFLQEVTSKKDQMQYWARRDEPYRFIRVR 461
Query: 274 DFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKRN 333
+F+EAFQSF VG+++ +ELA PFDK+K HP ALT KKYGV KEL+ SRE+LLMKRN
Sbjct: 462 EFAEAFQSFHVGRRIGDELALPFDKTKSHPAALTTKKYGVGIKELVKTSFSREYLLMKRN 521
Query: 334 SIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFLA 393
S VY FK QL+ +A
Sbjct: 522 SFVYYFKFG---------------------------------------------QLLVMA 536
Query: 394 VMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLLF 453
+ TLF RT+M + T DG Y GALFF + + MFNG+ EL MTI KLPVFYKQRDLLF
Sbjct: 537 FLTMTLFFRTEMQKKTEVDGSLYTGALFFILMMLMFNGMSELSMTIAKLPVFYKQRDLLF 596
Query: 454 YPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDPIFAR 494
YP+W YSLPPW+LKIPI+ +E A+ I+YY IG+DP R
Sbjct: 597 YPAWVYSLPPWLLKIPISFMEAALTTFITYYVIGFDPNVGR 637
Score = 99.4 bits (246), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 49/71 (69%), Positives = 56/71 (78%), Gaps = 2/71 (2%)
Query: 152 AKIKPDADVDASMKAAVLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRV 211
A IKPD D+D MKA G++T+V+TDYILKILGLEVCAD MVGD M+RGISGGQKKRV
Sbjct: 275 ANIKPDPDIDIFMKAMSTAGEKTNVMTDYILKILGLEVCADTMVGDDMLRGISGGQKKRV 334
Query: 212 TTDGHIVYQGP 222
TT +V GP
Sbjct: 335 TTGEMLV--GP 343
Score = 98.2 bits (243), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 41/83 (49%), Positives = 63/83 (75%)
Query: 21 QQVKQVGLDIPTVEVRFENLNVEAQVYVGARALPSLFKFFANVLEGFLYYLHIIRSPKNQ 80
+++ +VG+D+PT+EVRF++L VEA+V+VG RALP+ F +N + FL LH++ + K +
Sbjct: 107 KRIDRVGIDLPTIEVRFDHLKVEAEVHVGGRALPTFVNFISNFADKFLNTLHLVPNRKKK 166
Query: 81 LHVLQNISGIIKPQRMTLLLGPP 103
+L ++SGI+KP RM LLLGPP
Sbjct: 167 FTILNDVSGIVKPGRMALLLGPP 189
>AT1G66950.1 | Symbols: PDR11, ATPDR11 | pleiotropic drug resistance
11 | chr1:24978239-24984461 FORWARD LENGTH=1454
Length = 1454
Score = 287 bits (735), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 134/282 (47%), Positives = 179/282 (63%), Gaps = 45/282 (15%)
Query: 213 TDGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTV 272
++G IVYQGPR+NVLEFFE GF+CPERKGVADFLQEVTS+KDQ QYW +++PY +V+V
Sbjct: 422 SEGQIVYQGPRDNVLEFFEYFGFQCPERKGVADFLQEVTSKKDQEQYWNKREQPYNYVSV 481
Query: 273 KDFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKR 332
DFS F +F GQKL E P+DK+K H AL +KYG+++ EL C RE+LLMKR
Sbjct: 482 SDFSSGFSTFHTGQKLTSEFRVPYDKAKTHSAALVTQKYGISNWELFKACFDREWLLMKR 541
Query: 333 NSIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFL 392
NS VY+FK Q+ +
Sbjct: 542 NSFVYVFKTVQI---------------------------------------------TIM 556
Query: 393 AVMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLL 452
+++ T+++RT+MH TV DG + GA+FF++ MFNG+ EL T+++LPVFYKQRD L
Sbjct: 557 SLITMTVYLRTEMHVGTVRDGQKFYGAMFFSLINVMFNGLAELAFTVMRLPVFYKQRDFL 616
Query: 453 FYPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDPIFAR 494
FYP WA++LP W+LKIP++L+E IW G++YY IG+ P AR
Sbjct: 617 FYPPWAFALPAWLLKIPLSLIESGIWIGLTYYTIGFAPSAAR 658
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 39/83 (46%), Positives = 61/83 (73%)
Query: 21 QQVKQVGLDIPTVEVRFENLNVEAQVYVGARALPSLFKFFANVLEGFLYYLHIIRSPKNQ 80
++ +VG+++P +EVR+EN++VE V +RALP+LF N LE L + H++ S + +
Sbjct: 128 ERTDRVGIEVPKIEVRYENISVEGDVRSASRALPTLFNVTLNTLESILGFFHLLPSKRKK 187
Query: 81 LHVLQNISGIIKPQRMTLLLGPP 103
+ +L++ISGI+KP RMTLLLGPP
Sbjct: 188 IQILKDISGIVKPSRMTLLLGPP 210
Score = 93.2 bits (230), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 48/102 (47%), Positives = 65/102 (63%), Gaps = 2/102 (1%)
Query: 154 IKPDADVDASMKAAVLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRVTT 213
IKPD +DA MK+ + GQ+TS+VTDY+LKILGL++CADI+ GD M RGISGGQKKR+TT
Sbjct: 298 IKPDPKIDAFMKSIAISGQETSLVTDYVLKILGLDICADILAGDVMRRGISGGQKKRLTT 357
Query: 214 DGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKD 255
+V GP + S G + F++++ D
Sbjct: 358 GEMLV--GPARALFMDEISTGLDSSTTFQICKFMRQLVHISD 397
>AT2G36380.1 | Symbols: PDR6, ATPDR6 | pleiotropic drug resistance 6
| chr2:15257583-15263627 FORWARD LENGTH=1453
Length = 1453
Score = 283 bits (724), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 134/282 (47%), Positives = 180/282 (63%), Gaps = 45/282 (15%)
Query: 213 TDGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTV 272
++G IVYQG R+NVLEFFE MGFKCPERKG+ADFLQEVTS+KDQ QYW ++ PY +V+V
Sbjct: 420 SEGQIVYQGSRDNVLEFFEYMGFKCPERKGIADFLQEVTSKKDQEQYWNRREHPYSYVSV 479
Query: 273 KDFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKR 332
DFS F SF GQ+L E P+DK+K HP AL +KYG+++K+L C RE+LLMKR
Sbjct: 480 HDFSSGFNSFHAGQQLASEFRVPYDKAKTHPAALVTQKYGISNKDLFKACFDREWLLMKR 539
Query: 333 NSIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFL 392
NS VY+FK Q+ +
Sbjct: 540 NSFVYVFKTVQI---------------------------------------------TIM 554
Query: 393 AVMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLL 452
+++A T++ RT+MH TV+DG + GALFF++ MFNG+ EL T+++LPVF+KQRD L
Sbjct: 555 SLIAMTVYFRTEMHVGTVQDGQKFYGALFFSLINLMFNGMAELAFTVMRLPVFFKQRDFL 614
Query: 453 FYPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDPIFAR 494
FYP WA++LP ++LKIP++L+E IW ++YY IG+ P AR
Sbjct: 615 FYPPWAFALPGFLLKIPLSLIESVIWIALTYYTIGFAPSAAR 656
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 41/83 (49%), Positives = 60/83 (72%)
Query: 21 QQVKQVGLDIPTVEVRFENLNVEAQVYVGARALPSLFKFFANVLEGFLYYLHIIRSPKNQ 80
++ +VG+++P +EVR+ENL+VE V +RALP+LF N +E L H++ S K +
Sbjct: 126 ERTDRVGIEVPKIEVRYENLSVEGDVRSASRALPTLFNVTLNTIESILGLFHLLPSKKRK 185
Query: 81 LHVLQNISGIIKPQRMTLLLGPP 103
+ +L++ISGIIKP RMTLLLGPP
Sbjct: 186 IEILKDISGIIKPSRMTLLLGPP 208
Score = 92.8 bits (229), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 43/71 (60%), Positives = 57/71 (80%), Gaps = 2/71 (2%)
Query: 152 AKIKPDADVDASMKAAVLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRV 211
A IKPD ++DA MK+ + GQ+TS+VTDY+LK+LGL++CAD +VGD M RGISGGQ+KR+
Sbjct: 294 AGIKPDPEIDAFMKSIAISGQETSLVTDYVLKLLGLDICADTLVGDVMRRGISGGQRKRL 353
Query: 212 TTDGHIVYQGP 222
TT +V GP
Sbjct: 354 TTGEMLV--GP 362
>AT3G16340.2 | Symbols: PDR1 | pleiotropic drug resistance 1 |
chr3:5539897-5546263 FORWARD LENGTH=1411
Length = 1411
Score = 264 bits (675), Expect = 8e-71, Method: Compositional matrix adjust.
Identities = 149/403 (36%), Positives = 207/403 (51%), Gaps = 105/403 (26%)
Query: 152 AKIKPDADVDASMKAAVLEGQQTSVVTDYILKILGLE-----VCADIMV---GDGMIRGI 203
A I P+ +VD MK+ ++S++TDY L+ILGL+ V D M+ G + +
Sbjct: 268 AGILPEPEVDLFMKSIAAGNVKSSLITDYTLRILGLDICKDTVVGDEMIRGISGGQKKRV 327
Query: 204 SGGQKKRVTTD------------------------------------------------- 214
+ G K + D
Sbjct: 328 TTGPTKTLFMDEISTGLDSSTTYQIVKCLQEIVRFTDATVLMSLLQPAPETFELFDDIIL 387
Query: 215 ---GHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVT 271
G IVYQGPR++VL FFE+ GFKCP+RKG ADFLQEVTSRKDQ QYWA +PY +++
Sbjct: 388 LSEGQIVYQGPRDHVLTFFETCGFKCPDRKGTADFLQEVTSRKDQEQYWADSKKPYSYIS 447
Query: 272 VKDFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMK 331
V +FS+ F++F VG L ++L+ P+D+ K HP +L KK+ V +L VC RE LLMK
Sbjct: 448 VSEFSKRFRTFHVGANLEKDLSVPYDRFKSHPASLVFKKHSVPKSQLFKVCWDRELLLMK 507
Query: 332 RNSIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIF 391
RN+ YI K Q+ I
Sbjct: 508 RNAFFYITKTVQI---------------------------------------------II 522
Query: 392 LAVMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDL 451
+A++AST+++RT+M DG Y+GAL F++ V MFNG EL + I +LPVFYKQRDL
Sbjct: 523 MALIASTVYLRTEMGTKNESDGAVYIGALMFSMIVNMFNGFAELALMIQRLPVFYKQRDL 582
Query: 452 LFYPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDPIFAR 494
LF+P W +SLP ++L IPI++ E +W I+YY IG+ P +R
Sbjct: 583 LFHPPWTFSLPTFLLGIPISIFESVVWVTITYYMIGFAPELSR 625
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 37/83 (44%), Positives = 55/83 (66%)
Query: 21 QQVKQVGLDIPTVEVRFENLNVEAQVYVGARALPSLFKFFANVLEGFLYYLHIIRSPKNQ 80
++ +V + +PTVEVRFE + +EA ++G RALP+L N+ E L L + +
Sbjct: 100 NRIDRVRIKLPTVEVRFEKVTIEANCHIGKRALPTLPNAALNIAERGLRLLGFNFTKTTK 159
Query: 81 LHVLQNISGIIKPQRMTLLLGPP 103
+ +L+++SGIIKP RMTLLLGPP
Sbjct: 160 VTILRDVSGIIKPSRMTLLLGPP 182
>AT1G59870.1 | Symbols: PEN3, PDR8, ATPDR8, ABCG36, ATABCG36 | ABC-2
and Plant PDR ABC-type transporter family protein |
chr1:22034661-22039844 FORWARD LENGTH=1469
Length = 1469
Score = 263 bits (672), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 127/284 (44%), Positives = 172/284 (60%), Gaps = 45/284 (15%)
Query: 211 VTTDGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFV 270
+ ++G IVYQGPR+N+LEFFES GFKCPERKG ADFLQEVTS+KDQ QYW + PY ++
Sbjct: 416 LVSEGQIVYQGPRDNILEFFESFGFKCPERKGTADFLQEVTSKKDQEQYWVNPNRPYHYI 475
Query: 271 TVKDFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLM 330
V +F+ ++SF VG K+ ELA PFDKS+ H AL KY V+ +ELL C +E+LLM
Sbjct: 476 PVSEFASRYKSFHVGTKMSNELAVPFDKSRGHKAALVFDKYSVSKRELLKSCWDKEWLLM 535
Query: 331 KRNSIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLI 390
+RN+ Y+FK Q+ +
Sbjct: 536 QRNAFFYVFKTVQI---------------------------------------------V 550
Query: 391 FLAVMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRD 450
+A + STLF+RT+M+ D Y+GAL F + + MFNG E+ M + +LPVFYKQRD
Sbjct: 551 IIAAITSTLFLRTEMNTRNEGDANLYIGALLFGMIINMFNGFAEMAMMVSRLPVFYKQRD 610
Query: 451 LLFYPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDPIFAR 494
LLFYPSW +SLP ++L IP ++LE W ++YY+IG+ P +R
Sbjct: 611 LLFYPSWTFSLPTFLLGIPSSILESTAWMVVTYYSIGFAPDASR 654
Score = 89.7 bits (221), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 49/99 (49%), Positives = 63/99 (63%), Gaps = 2/99 (2%)
Query: 152 AKIKPDADVDASMKAAVLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRV 211
A I P+ADVD MKA+ +G + S+VTDY LKILGL++C D +VGD M+RGISGGQKKRV
Sbjct: 292 AGIFPEADVDLFMKASAAQGVKNSLVTDYTLKILGLDICKDTIVGDDMMRGISGGQKKRV 351
Query: 212 TTDGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEV 250
TT IV GP + + S G + LQ++
Sbjct: 352 TTGEMIV--GPTKTLFMDEISTGLDSSTTFQIVKCLQQI 388
Score = 85.9 bits (211), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 41/88 (46%), Positives = 60/88 (68%)
Query: 16 FTFMIQQVKQVGLDIPTVEVRFENLNVEAQVYVGARALPSLFKFFANVLEGFLYYLHIIR 75
T + ++ +VG+ +PTVEVR+E+L ++A Y G R+LP+L N+ E L + I
Sbjct: 119 LTKLRNRIDRVGIKLPTVEVRYEHLTIKADCYTGNRSLPTLLNVVRNMGESALGMIGIQF 178
Query: 76 SPKNQLHVLQNISGIIKPQRMTLLLGPP 103
+ K QL +L++ISG+IKP RMTLLLGPP
Sbjct: 179 AKKAQLTILKDISGVIKPGRMTLLLGPP 206
>AT2G26910.1 | Symbols: PDR4, ATPDR4 | pleiotropic drug resistance 4
| chr2:11481623-11487874 FORWARD LENGTH=1420
Length = 1420
Score = 259 bits (662), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 122/282 (43%), Positives = 173/282 (61%), Gaps = 45/282 (15%)
Query: 213 TDGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTV 272
++G I+YQGPR+ VL+FF S+GF CP+RK VADFLQEVTS+KDQ QYW+ PYR+V
Sbjct: 382 SEGQIIYQGPRDEVLDFFSSLGFTCPDRKNVADFLQEVTSKKDQQQYWSVPFRPYRYVPP 441
Query: 273 KDFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKR 332
F+EAF+S+ G+KL ++L PFDK H AL+ +YGV ELL + + + LMK+
Sbjct: 442 GKFAEAFRSYPTGKKLAKKLEVPFDKRFNHSAALSTSQYGVKKSELLKINFAWQKQLMKQ 501
Query: 333 NSIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFL 392
N+ +Y+FK QL+ +
Sbjct: 502 NAFIYVFKFV---------------------------------------------QLLLV 516
Query: 393 AVMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLL 452
A++ T+F RT MH +T++DG Y+G+L+F++ + +FNG E+ M + KLPV YK RDL
Sbjct: 517 ALITMTVFCRTTMHHNTIDDGNIYLGSLYFSMVIILFNGFTEVPMLVAKLPVLYKHRDLH 576
Query: 453 FYPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDPIFAR 494
FYPSWAY+LP W+L IP +++E A W ++YY IGYDP+F+R
Sbjct: 577 FYPSWAYTLPSWLLSIPTSIIESATWVAVTYYTIGYDPLFSR 618
Score = 147 bits (370), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 87/239 (36%), Positives = 119/239 (49%), Gaps = 39/239 (16%)
Query: 21 QQVKQVGLDIPTVEVRFENLNVEAQVYVGARALPSLFKFFANVLEGFLYYLHIIRSPKNQ 80
++ V L P +EVRF+NL VE+ V+VG+RALP++ F N+ EG L +H+I +N+
Sbjct: 88 KRFDAVDLKFPKIEVRFQNLMVESFVHVGSRALPTIPNFIINMAEGLLRNIHVIGGKRNK 147
Query: 81 LHVLQNISGIIKPQRMTLLLGPPXXXXXXXXXXXXXXXX--------------------- 119
L +L ISG+I+P R+TLLLGPP
Sbjct: 148 LTILDGISGVIRPSRLTLLLGPPSSGKTTLLLALAGRLGTNLQTSGKITYNGYDLKEIIA 207
Query: 120 --XXXXVRRQHHHC--------------CEWNSFXXXXXXXXXXXXXXAKIKPDADVDAS 163
V +Q H C+ F A I PD D+D
Sbjct: 208 PRTSAYVSQQDWHVAEMTVRQTLEFAGRCQGVGFKYDMLLELARREKLAGIVPDEDLDIF 267
Query: 164 MKAAVLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRVTTDGHIVYQGP 222
MK+ L G +TS+V +Y++KILGL+ CAD +VGD MI+GISGGQKKR+TT +V GP
Sbjct: 268 MKSLALGGMETSLVVEYVMKILGLDTCADTLVGDEMIKGISGGQKKRLTTGELLV--GP 324
>AT3G16340.1 | Symbols: ATPDR1, PDR1 | pleiotropic drug resistance 1
| chr3:5539897-5546263 FORWARD LENGTH=1416
Length = 1416
Score = 258 bits (660), Expect = 6e-69, Method: Compositional matrix adjust.
Identities = 126/282 (44%), Positives = 172/282 (60%), Gaps = 45/282 (15%)
Query: 213 TDGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTV 272
++G IVYQGPR++VL FFE+ GFKCP+RKG ADFLQEVTSRKDQ QYWA +PY +++V
Sbjct: 394 SEGQIVYQGPRDHVLTFFETCGFKCPDRKGTADFLQEVTSRKDQEQYWADSKKPYSYISV 453
Query: 273 KDFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKR 332
+FS+ F++F VG L ++L+ P+D+ K HP +L KK+ V +L VC RE LLMKR
Sbjct: 454 SEFSKRFRTFHVGANLEKDLSVPYDRFKSHPASLVFKKHSVPKSQLFKVCWDRELLLMKR 513
Query: 333 NSIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFL 392
N+ YI K Q+ I +
Sbjct: 514 NAFFYITKTVQI---------------------------------------------IIM 528
Query: 393 AVMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLL 452
A++AST+++RT+M DG Y+GAL F++ V MFNG EL + I +LPVFYKQRDLL
Sbjct: 529 ALIASTVYLRTEMGTKNESDGAVYIGALMFSMIVNMFNGFAELALMIQRLPVFYKQRDLL 588
Query: 453 FYPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDPIFAR 494
F+P W +SLP ++L IPI++ E +W I+YY IG+ P +R
Sbjct: 589 FHPPWTFSLPTFLLGIPISIFESVVWVTITYYMIGFAPELSR 630
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 37/83 (44%), Positives = 55/83 (66%)
Query: 21 QQVKQVGLDIPTVEVRFENLNVEAQVYVGARALPSLFKFFANVLEGFLYYLHIIRSPKNQ 80
++ +V + +PTVEVRFE + +EA ++G RALP+L N+ E L L + +
Sbjct: 100 NRIDRVRIKLPTVEVRFEKVTIEANCHIGKRALPTLPNAALNIAERGLRLLGFNFTKTTK 159
Query: 81 LHVLQNISGIIKPQRMTLLLGPP 103
+ +L+++SGIIKP RMTLLLGPP
Sbjct: 160 VTILRDVSGIIKPSRMTLLLGPP 182
>AT1G15210.1 | Symbols: PDR7, ATPDR7 | pleiotropic drug resistance 7
| chr1:5231552-5236573 REVERSE LENGTH=1442
Length = 1442
Score = 258 bits (659), Expect = 6e-69, Method: Compositional matrix adjust.
Identities = 127/278 (45%), Positives = 168/278 (60%), Gaps = 45/278 (16%)
Query: 213 TDGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTV 272
++G IVYQGPR+++LEFFES GFKCPERKG ADFLQEVTS+KDQ QYW + PYR++ V
Sbjct: 416 SEGQIVYQGPRDHILEFFESFGFKCPERKGTADFLQEVTSKKDQEQYWVDPNRPYRYIPV 475
Query: 273 KDFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKR 332
+F+ +F+ F VG KL EL+ P+DKSK H AL KY + ELL C +E++LMKR
Sbjct: 476 SEFASSFKKFHVGSKLSNELSVPYDKSKSHKAALMFDKYSIKKTELLKSCWDKEWMLMKR 535
Query: 333 NSIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFL 392
NS Y+FK Q+ +
Sbjct: 536 NSFFYVFKTVQIII---------------------------------------------I 550
Query: 393 AVMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLL 452
A + STL++RT+MH D Y+G+L F + V MFNG+ E+ MTI +LPVFYKQRDLL
Sbjct: 551 AAITSTLYLRTEMHTRNEIDANIYVGSLLFAMIVNMFNGLAEMAMTIQRLPVFYKQRDLL 610
Query: 453 FYPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDP 490
F+P W Y+LP ++L IPI++ E W ++YY+IGY P
Sbjct: 611 FHPPWTYTLPTFLLGIPISIFESTAWMVVTYYSIGYAP 648
Score = 90.1 bits (222), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 48/99 (48%), Positives = 64/99 (64%), Gaps = 2/99 (2%)
Query: 152 AKIKPDADVDASMKAAVLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRV 211
A I P+ADVD MKA+ +G ++S++TDY LKILGL++C D +VGD M+RGISGGQKKRV
Sbjct: 290 AGIFPEADVDLFMKASAAQGVKSSLITDYTLKILGLDICKDTIVGDDMMRGISGGQKKRV 349
Query: 212 TTDGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEV 250
TT IV GP + + S G + LQ++
Sbjct: 350 TTGEMIV--GPTKTLFMDEISTGLDSSTTFQIVKCLQQI 386
Score = 86.7 bits (213), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 41/88 (46%), Positives = 60/88 (68%)
Query: 16 FTFMIQQVKQVGLDIPTVEVRFENLNVEAQVYVGARALPSLFKFFANVLEGFLYYLHIIR 75
T + ++ +VG+ +PTVEVR+++L V+A Y G R+LPSL N+ E L + I
Sbjct: 117 LTKLRNRIDRVGIQLPTVEVRYDHLTVKADCYTGDRSLPSLLNAVRNMGEAALGMIGIRL 176
Query: 76 SPKNQLHVLQNISGIIKPQRMTLLLGPP 103
+ K QL +L+++SGI+KP RMTLLLGPP
Sbjct: 177 AKKAQLTILKDVSGIVKPSRMTLLLGPP 204
>AT4G15215.1 | Symbols: PDR13, ATPDR13 | pleiotropic drug resistance
13 | chr4:8672070-8678874 FORWARD LENGTH=1390
Length = 1390
Score = 258 bits (659), Expect = 7e-69, Method: Compositional matrix adjust.
Identities = 179/565 (31%), Positives = 255/565 (45%), Gaps = 137/565 (24%)
Query: 21 QQVKQVGLDIPTVEVRFENLNVEAQV-YVGARALPSLFKFFANVLE-----------GFL 68
+++ +VG+++PTVEVRF +L+VEA+ V + +P+L+ L G L
Sbjct: 95 KRIDEVGIELPTVEVRFNDLSVEAECQVVHGKPIPTLWNTIKGSLSKFVCSKKETKIGIL 154
Query: 69 YYLHIIRSPK-----------NQLHVLQNISGII--------KPQRMTLLLGPPXXXXXX 109
+ I P + +LQ +SG + K LL
Sbjct: 155 KGVSGIVRPGRMTLLLGPPGCGKTTLLQALSGRLSHSVKVGGKVSYNGCLLSEFIPEKTS 214
Query: 110 XXXXXXXXXXXXXXVRR--QHHHCCEWNSFXXXXXXXXXXXXXXAKIKPDADVDASMKAA 167
VR CC+ +I PD D+DA MKA
Sbjct: 215 SYISQNDLHIPELSVRETLDFSACCQGIGSRMEIMKEISRREKLKEIVPDPDIDAYMKAI 274
Query: 168 VLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRVTT-------------D 214
+EG + S+ TDYILKILGL++CAD GD GISGGQK+R+TT D
Sbjct: 275 SVEGLKNSMQTDYILKILGLDICADTRAGDATRPGISGGQKRRLTTATTLLMDEISNGLD 334
Query: 215 GHIVYQ---------------------GPRENVLEFF----------------------- 230
+Q P E F
Sbjct: 335 SSTTFQIVSCLQQLAHIAGATILISLLQPAPETFELFDDVILLGEGKIIYHAPRADICKF 394
Query: 231 -ESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTVKDFSEAFQSFDVGQKLR 289
E GFKCPERKGVADFLQEV SRKDQ QYW ++ +PY +++V F + F ++G L+
Sbjct: 395 FEGCGFKCPERKGVADFLQEVMSRKDQEQYWCHRSKPYSYISVDSFIKKFNESNLGFLLK 454
Query: 290 EELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKRNSIVYIFKVTQVRNIQA 349
EEL+ PFDKS+ ++L +KY ++ E+L C+ RE LLMKRNS +Y+FK
Sbjct: 455 EELSKPFDKSQTRKDSLCFRKYSLSKWEMLKACSRREILLMKRNSFIYLFK--------- 505
Query: 350 LMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFLAVMASTLFIRTKMHRDT 409
S L L+F A++ T+F++ RD
Sbjct: 506 ------SGL------------------------------LVFNALVTMTVFLQAGATRD- 528
Query: 410 VEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLLFYPSWAYSLPPWILKIP 469
G MG++F + + +G+ EL +TI +L VF KQ+DL FYP+WAY++P IL+IP
Sbjct: 529 ARHGNYLMGSMFTALFRLLADGLPELTLTISRLGVFCKQKDLYFYPAWAYAIPSIILRIP 588
Query: 470 ITLLEVAIWEGISYYAIGYDPIFAR 494
+++L+ IW ++YY IGY P R
Sbjct: 589 LSVLDSFIWTVLTYYVIGYSPEVGR 613
>AT3G30842.1 | Symbols: PDR10, ATPDR10 | pleiotropic drug resistance
10 | chr3:12593959-12600432 REVERSE LENGTH=1406
Length = 1406
Score = 243 bits (621), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 126/276 (45%), Positives = 161/276 (58%), Gaps = 45/276 (16%)
Query: 214 DGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTVK 273
+GHIVYQGPRE+VLEFFE MGFKCPERKG+AD+LQE+ S+KDQ QYWA + PYR+VT K
Sbjct: 394 EGHIVYQGPREDVLEFFEFMGFKCPERKGIADYLQEILSKKDQEQYWANPELPYRYVTAK 453
Query: 274 DFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKRN 333
F E F+ G+ +R +LA PFD+ K H ALT+ YG + ELL C RE +LMKRN
Sbjct: 454 KFEEGFKIHHFGRAMRSQLATPFDRLKNHRAALTRTTYGASKLELLKACLERESILMKRN 513
Query: 334 SIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFLA 393
++ K QLI A
Sbjct: 514 LRTFVLK---------------------------------------------SLQLIINA 528
Query: 394 VMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLLF 453
++ +F + K + TVEDG YMGA++ V + +F+G EL MTI KLPVFYKQR F
Sbjct: 529 ILIGVVFWQQKNYPSTVEDGIIYMGAIYLEVQMIVFSGFFELPMTIDKLPVFYKQRHFSF 588
Query: 454 YPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYD 489
YPSWA+SLP I+ P++ +EV I I+Y+ IGYD
Sbjct: 589 YPSWAFSLPTSIITFPLSFVEVFIVVLITYFTIGYD 624
Score = 84.3 bits (207), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 35/79 (44%), Positives = 57/79 (72%)
Query: 25 QVGLDIPTVEVRFENLNVEAQVYVGARALPSLFKFFANVLEGFLYYLHIIRSPKNQLHVL 84
+V L +PT+EVRFE+LNV A+ Y G++ +P++ + N+L+G + ++ K ++ +L
Sbjct: 103 RVSLHLPTIEVRFEDLNVTAEAYAGSKTVPTVLNSYVNLLKGIGTKIRVLPDRKKRISIL 162
Query: 85 QNISGIIKPQRMTLLLGPP 103
++SGIIKP R+TLLLGPP
Sbjct: 163 NDVSGIIKPGRLTLLLGPP 181
>AT2G37280.1 | Symbols: PDR5, ATPDR5 | pleiotropic drug resistance 5
| chr2:15650400-15656417 FORWARD LENGTH=1413
Length = 1413
Score = 242 bits (618), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 120/277 (43%), Positives = 164/277 (59%), Gaps = 46/277 (16%)
Query: 214 DGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTVK 273
+G IVY GPR++VL+FFE GF+CPERKGVADFLQEV S+KDQ QYW +++ P+ FV+V
Sbjct: 387 EGKIVYHGPRDDVLKFFEECGFQCPERKGVADFLQEVISKKDQGQYWLHQNLPHSFVSVD 446
Query: 274 DFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKRN 333
S+ F+ ++G+K+ E L+ P+D SK H +AL+ Y + EL C SREFLLMKRN
Sbjct: 447 TLSKRFKDLEIGRKIEEALSKPYDISKTHKDALSFNVYSLPKWELFRACISREFLLMKRN 506
Query: 334 SIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFLA 393
VY+FK FQL+ A
Sbjct: 507 YFVYLFKT---------------------------------------------FQLVLAA 521
Query: 394 VMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLLF 453
++ T+FIRT+M D + G +YM LFF V + +GI EL MT+ +L VFYKQ+ L F
Sbjct: 522 IITMTVFIRTRMDIDIIH-GNSYMSCLFFATVVLLVDGIPELSMTVQRLSVFYKQKQLCF 580
Query: 454 YPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDP 490
YP+WAY++P +LKIP++ E +W ++YY IGY P
Sbjct: 581 YPAWAYAIPATVLKIPLSFFESLVWTCLTYYVIGYTP 617
Score = 82.8 bits (203), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 41/69 (59%), Positives = 53/69 (76%), Gaps = 2/69 (2%)
Query: 154 IKPDADVDASMKAAVLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRVTT 213
I PD ++DA MKA ++G + S+ TDYILKILGL++CA+ +VG+ M RGISGGQKKR+TT
Sbjct: 262 IIPDPEIDAYMKAISVKGLKRSLQTDYILKILGLDICAETLVGNAMKRGISGGQKKRLTT 321
Query: 214 DGHIVYQGP 222
IV GP
Sbjct: 322 AEMIV--GP 328
Score = 67.0 bits (162), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 34/84 (40%), Positives = 57/84 (67%), Gaps = 2/84 (2%)
Query: 21 QQVKQVGLDIPTVEVRFENLNVEAQV-YVGARALPSLFKFFANVLEGFLYYLHIIRSPKN 79
+++++VG++ P++EVR+E+L VEA V +ALP+L+ +V L L +R+ +
Sbjct: 92 RRMERVGVEFPSIEVRYEHLGVEAACEVVEGKALPTLWNSLKHVFLDLLK-LSGVRTNEA 150
Query: 80 QLHVLQNISGIIKPQRMTLLLGPP 103
+ +L ++SGII P R+TLLLGPP
Sbjct: 151 NIKILTDVSGIISPGRLTLLLGPP 174
>AT3G53480.1 | Symbols: PIS1, PDR9, ATPDR9, ABCG37 | pleiotropic
drug resistance 9 | chr3:19825366-19831644 FORWARD
LENGTH=1450
Length = 1450
Score = 238 bits (606), Expect = 9e-63, Method: Compositional matrix adjust.
Identities = 120/280 (42%), Positives = 162/280 (57%), Gaps = 46/280 (16%)
Query: 215 GHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTVKD 274
G IVY GPR VL FFE GF+CPERKGVADFLQEV S+KDQ QYW ++D PY FV+V+
Sbjct: 423 GRIVYHGPRGEVLNFFEDCGFRCPERKGVADFLQEVISKKDQAQYWWHEDLPYSFVSVEM 482
Query: 275 FSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKRNS 334
S+ F+ +G+K+ + L+ P+D+SK H +AL+ Y + + EL C SRE+LLMKRN
Sbjct: 483 LSKKFKDLSIGKKIEDTLSKPYDRSKSHKDALSFSVYSLPNWELFIACISREYLLMKRNY 542
Query: 335 IVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFLAV 394
VYIFK QL+ A
Sbjct: 543 FVYIFKTA---------------------------------------------QLVMAAF 557
Query: 395 MASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLLFY 454
+ T+FIRT+M D + G +YM ALFF + + + +G EL MT +L VFYKQ+ L FY
Sbjct: 558 ITMTVFIRTRMGIDIIH-GNSYMSALFFALIILLVDGFPELSMTAQRLAVFYKQKQLCFY 616
Query: 455 PSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDPIFAR 494
P+WAY++P +LK+P++ E +W +SYY IGY P +R
Sbjct: 617 PAWAYAIPATVLKVPLSFFESLVWTCLSYYVIGYTPEASR 656
Score = 88.6 bits (218), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 45/69 (65%), Positives = 54/69 (78%), Gaps = 2/69 (2%)
Query: 154 IKPDADVDASMKAAVLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRVTT 213
I PD +VDA MKA +EG Q S+ TDYILKILGL++CA+I++GD M RGISGGQKKR+TT
Sbjct: 297 IIPDTEVDAYMKAISVEGLQRSLQTDYILKILGLDICAEILIGDVMRRGISGGQKKRLTT 356
Query: 214 DGHIVYQGP 222
IV GP
Sbjct: 357 AEMIV--GP 363
Score = 65.9 bits (159), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 33/84 (39%), Positives = 59/84 (70%), Gaps = 2/84 (2%)
Query: 21 QQVKQVGLDIPTVEVRFENLNVEAQV-YVGARALPSLFKFFANVLEGFLYYLHIIRSPKN 79
+++ +VG+++PT+EVR+E+L V A+ V +ALP+L+ VL L L ++ +
Sbjct: 127 RRIDRVGMELPTIEVRYESLKVVAECEVVEGKALPTLWNTAKRVLSE-LVKLTGAKTHEA 185
Query: 80 QLHVLQNISGIIKPQRMTLLLGPP 103
+++++ +++GIIKP R+TLLLGPP
Sbjct: 186 KINIINDVNGIIKPGRLTLLLGPP 209
>AT2G29940.1 | Symbols: PDR3, ATPDR3 | pleiotropic drug resistance 3
| chr2:12760139-12766455 FORWARD LENGTH=1426
Length = 1426
Score = 229 bits (583), Expect = 5e-60, Method: Compositional matrix adjust.
Identities = 109/282 (38%), Positives = 163/282 (57%), Gaps = 45/282 (15%)
Query: 213 TDGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTV 272
++G++VYQGPRE+V+ FFES+GF+ P RKGVADFLQEVTS+KDQ QYWA +PY+F+ V
Sbjct: 408 SEGYMVYQGPREDVIAFFESLGFRLPPRKGVADFLQEVTSKKDQAQYWADPSKPYQFIPV 467
Query: 273 KDFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKR 332
D + AF++ G +LA PFDK P+AL + K+ ++ E L VC RE LL+KR
Sbjct: 468 SDIAAAFRNSKYGHAADSKLAAPFDKKSADPSALCRTKFAISGWENLKVCFVRELLLIKR 527
Query: 333 NSIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFL 392
+ +Y F+ QV F+
Sbjct: 528 HKFLYTFRTCQVG---------------------------------------------FV 542
Query: 393 AVMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLL 452
++ +T+F++T++H + + G Y+ LFF + MFNG EL + I +LPVFYKQRD
Sbjct: 543 GLVTATVFLKTRLHPTSEQFGNEYLSCLFFGLVHMMFNGFSELPLMISRLPVFYKQRDNS 602
Query: 453 FYPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDPIFAR 494
F+P+W++S+ W+L++P ++LE +W G+ Y+ +G P R
Sbjct: 603 FHPAWSWSIASWLLRVPYSVLEAVVWSGVVYFTVGLAPSAGR 644
Score = 95.1 bits (235), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 44/83 (53%), Positives = 62/83 (74%)
Query: 21 QQVKQVGLDIPTVEVRFENLNVEAQVYVGARALPSLFKFFANVLEGFLYYLHIIRSPKNQ 80
+++ +VG+++P +EVRFENLN+EA V G RALP+L + E L L II+ K++
Sbjct: 113 ERLDRVGMEVPKIEVRFENLNIEADVQAGTRALPTLVNVSRDFFERCLSSLRIIKPRKHK 172
Query: 81 LHVLQNISGIIKPQRMTLLLGPP 103
L++L++ISGIIKP RMTLLLGPP
Sbjct: 173 LNILKDISGIIKPGRMTLLLGPP 195
Score = 91.7 bits (226), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 41/74 (55%), Positives = 59/74 (79%), Gaps = 2/74 (2%)
Query: 154 IKPDADVDASMKAAVLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRVTT 213
I+P +++DA MKAA ++G++ SV TDY+LK+LGL+VC+D MVG+ M+RG+SGGQ+KRVTT
Sbjct: 284 IRPSSEIDAFMKAASVKGEKHSVSTDYVLKVLGLDVCSDTMVGNDMMRGVSGGQRKRVTT 343
Query: 214 DGHIVYQGPRENVL 227
V GPR+ +
Sbjct: 344 GEMTV--GPRKTLF 355
>AT4G15230.1 | Symbols: ATPDR2, PDR2 | pleiotropic drug resistance 2
| chr4:8680295-8686880 FORWARD LENGTH=1400
Length = 1400
Score = 220 bits (561), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 113/281 (40%), Positives = 163/281 (58%), Gaps = 46/281 (16%)
Query: 214 DGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTVK 273
+G I+Y PR ++ FFE GFKCPERKGVADFLQE+ S+KDQ QYW ++D+PY +++V
Sbjct: 389 EGKIIYHAPRADICRFFEEFGFKCPERKGVADFLQEIMSKKDQEQYWCHRDKPYSYISVD 448
Query: 274 DFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKRN 333
F F+ ++G L+EEL+ PF+KS+ + L KKY + E+L C+ REFLLMKRN
Sbjct: 449 SFINKFKESNLGLLLKEELSKPFNKSQTRKDGLCYKKYSLGKWEMLKACSRREFLLMKRN 508
Query: 334 SIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFLA 393
S +Y+FK AL L+F A
Sbjct: 509 SFIYLFK-------SAL--------------------------------------LVFNA 523
Query: 394 VMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLLF 453
++ T+F++ D++ G MG+LF + + +G+ EL +TI +L VF KQ+DL F
Sbjct: 524 LVTMTVFLQVGATTDSLH-GNYLMGSLFTALFRLLADGLPELTLTISRLGVFCKQKDLYF 582
Query: 454 YPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDPIFAR 494
YP+WAY++P ILKIP+++L+ IW ++YY IGY P R
Sbjct: 583 YPAWAYAIPSIILKIPLSVLDSFIWTLLTYYVIGYSPEVKR 623
Score = 77.8 bits (190), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 39/70 (55%), Positives = 50/70 (71%), Gaps = 2/70 (2%)
Query: 153 KIKPDADVDASMKAAVLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRVT 212
+I PD VDA MKA +EG + ++ TDYILKILGL++CAD VGD GISGG+K+R+T
Sbjct: 263 EIIPDPAVDAYMKATSVEGLKNNLQTDYILKILGLDICADTRVGDATRPGISGGEKRRLT 322
Query: 213 TDGHIVYQGP 222
T +V GP
Sbjct: 323 TGELVV--GP 330
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 34/84 (40%), Positives = 56/84 (66%), Gaps = 6/84 (7%)
Query: 21 QQVKQVGLDIPTVEVRFENLNVEAQVYV-GARALPSLFKFFANVLEGFLYYLHIIRSPKN 79
+++ +VG+++PTVEVRF NL+VEA+ V + +P+L+ +L F I +
Sbjct: 98 KRIDKVGIELPTVEVRFNNLSVEAECQVIHGKPIPTLWNTIKGLLSEF-----ICSKKET 152
Query: 80 QLHVLQNISGIIKPQRMTLLLGPP 103
++ +L+ +SGI++P RMTLLLGPP
Sbjct: 153 KIGILKGVSGIVRPGRMTLLLGPP 176
>AT4G15236.1 | Symbols: | ABC-2 and Plant PDR ABC-type transporter
family protein | chr4:8696683-8702727 FORWARD
LENGTH=1388
Length = 1388
Score = 220 bits (560), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 111/281 (39%), Positives = 167/281 (59%), Gaps = 46/281 (16%)
Query: 214 DGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTVK 273
+G I+Y GPR+ + FFE GFKCP+RK VA+FLQEV SRKDQ QYW ++D+PY +V++
Sbjct: 384 EGKIIYHGPRDFICSFFEDCGFKCPQRKSVAEFLQEVISRKDQEQYWCHRDKPYCYVSID 443
Query: 274 DFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKRN 333
F E F+ D+G +L++EL+ +DKS+ + L +KY +++ ++ C+ REFLLMKRN
Sbjct: 444 SFIEKFKKSDLGLQLQDELSKTYDKSQTQKDGLCIRKYSLSNWDMFKACSRREFLLMKRN 503
Query: 334 SIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFLA 393
S VY+FK S L LIF+
Sbjct: 504 SFVYVFK---------------SGL------------------------------LIFIG 518
Query: 394 VMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLLF 453
+A T+++RT RD++ +G+LFF++ + +G+ EL +T+ ++ VF KQ++L F
Sbjct: 519 SIAMTVYLRTGSTRDSLH-ANYLLGSLFFSLIKLLADGLPELTLTVSRIAVFCKQKELYF 577
Query: 454 YPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDPIFAR 494
YP+WAY++P ILKIPI+ LE +W ++YY IGY P R
Sbjct: 578 YPAWAYAIPSAILKIPISFLESFLWTMLTYYVIGYSPEAGR 618
Score = 85.9 bits (211), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 43/69 (62%), Positives = 51/69 (73%), Gaps = 2/69 (2%)
Query: 154 IKPDADVDASMKAAVLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRVTT 213
I PD D+DA MKAA +EG +T++ TDYILKILGL +CAD VGD GISGGQK+R+TT
Sbjct: 259 IVPDPDIDAYMKAASIEGSKTNLQTDYILKILGLTICADTRVGDASRPGISGGQKRRLTT 318
Query: 214 DGHIVYQGP 222
IV GP
Sbjct: 319 GEMIV--GP 325
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 36/100 (36%), Positives = 64/100 (64%), Gaps = 12/100 (12%)
Query: 9 HIATDMKFTFMIQQVK----QVGLDIPTVEVRFENLNVEAQV-YVGARALPSLFKFFANV 63
H+ D + ++Q+++ +VG+D+P +EVRF +L VEA+ V + +P+L+ A+
Sbjct: 79 HVEDDNRV--LLQKIRTRTDEVGIDLPKIEVRFSDLFVEAECEVVHGKPIPTLWNAIASK 136
Query: 64 LEGFLYYLHIIRSPKNQLHVLQNISGIIKPQRMTLLLGPP 103
L F + ++++ +L+ +SGII+P+RMTLLLGPP
Sbjct: 137 LSRFTF-----SKQEDKISILKGVSGIIRPKRMTLLLGPP 171
>AT4G15233.1 | Symbols: | ABC-2 and Plant PDR ABC-type transporter
family protein | chr4:8688322-8694432 FORWARD
LENGTH=1311
Length = 1311
Score = 215 bits (547), Expect = 6e-56, Method: Compositional matrix adjust.
Identities = 112/281 (39%), Positives = 165/281 (58%), Gaps = 46/281 (16%)
Query: 214 DGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTVK 273
+G I+Y GPR+ V FFE GFKCP RK VA+FLQEV SRKDQ QYW + ++ Y +V+++
Sbjct: 370 EGKIIYHGPRDFVCSFFEDCGFKCPNRKSVAEFLQEVISRKDQEQYWCHIEKTYCYVSIE 429
Query: 274 DFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKRN 333
F E F+ D+G +L++ L+ +DKS+ + L +KY +++ ++L C+ REFLLMKRN
Sbjct: 430 SFIEKFKKSDLGLELQDRLSKTYDKSQTQKDGLCFRKYSLSNWDMLKACSRREFLLMKRN 489
Query: 334 SIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFLA 393
S VY+FK S L LIF+
Sbjct: 490 SFVYVFK---------------SGL------------------------------LIFIG 504
Query: 394 VMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLLF 453
+A T+++RT RD++ MG+LFF++ + +G+ EL +TI ++ VF KQ++L F
Sbjct: 505 FIAMTVYLRTGSTRDSLH-ANYLMGSLFFSLFKLLADGLPELTLTISRIAVFCKQKELYF 563
Query: 454 YPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDPIFAR 494
YP+WAY++P ILKIPI+ LE +W ++YY IGY P R
Sbjct: 564 YPAWAYAIPSAILKIPISFLESFLWTMLTYYVIGYSPEMGR 604
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 31/84 (36%), Positives = 55/84 (65%), Gaps = 6/84 (7%)
Query: 21 QQVKQVGLDIPTVEVRFENLNVEAQV-YVGARALPSLFKFFANVLEGFLYYLHIIRSPKN 79
+++ +VG+D+P +E RF +L VEA+ V + +P+L+ ++ L F+ +
Sbjct: 97 KRIDEVGIDLPKIEARFSDLFVEAECEVVYGKPIPTLWNAISSKLSRFM-----CSNQAK 151
Query: 80 QLHVLQNISGIIKPQRMTLLLGPP 103
++ +L+ +SGII+P+RMTLLLGPP
Sbjct: 152 KISILKGVSGIIRPKRMTLLLGPP 175
Score = 53.1 bits (126), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 32/69 (46%), Positives = 36/69 (52%), Gaps = 20/69 (28%)
Query: 154 IKPDADVDASMKAAVLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRVTT 213
I PD D+DA MK ILGL +CAD VGD GISGGQK+R+TT
Sbjct: 263 IVPDPDIDAYMK------------------ILGLTICADTRVGDASRPGISGGQKRRLTT 304
Query: 214 DGHIVYQGP 222
IV GP
Sbjct: 305 GEMIV--GP 311
>AT4G15233.2 | Symbols: | ABC-2 and Plant PDR ABC-type transporter
family protein | chr4:8688322-8694539 FORWARD
LENGTH=1382
Length = 1382
Score = 215 bits (547), Expect = 7e-56, Method: Compositional matrix adjust.
Identities = 112/281 (39%), Positives = 165/281 (58%), Gaps = 46/281 (16%)
Query: 214 DGHIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQWQYWAYKDEPYRFVTVK 273
+G I+Y GPR+ V FFE GFKCP RK VA+FLQEV SRKDQ QYW + ++ Y +V+++
Sbjct: 388 EGKIIYHGPRDFVCSFFEDCGFKCPNRKSVAEFLQEVISRKDQEQYWCHIEKTYCYVSIE 447
Query: 274 DFSEAFQSFDVGQKLREELANPFDKSKCHPNALTKKKYGVNSKELLSVCASREFLLMKRN 333
F E F+ D+G +L++ L+ +DKS+ + L +KY +++ ++L C+ REFLLMKRN
Sbjct: 448 SFIEKFKKSDLGLELQDRLSKTYDKSQTQKDGLCFRKYSLSNWDMLKACSRREFLLMKRN 507
Query: 334 SIVYIFKVTQVRNIQALMLLILSDLKNHVIYELKCLNAVFHTFLCTNACRIPRFQLIFLA 393
S VY+FK S L LIF+
Sbjct: 508 SFVYVFK---------------SGL------------------------------LIFIG 522
Query: 394 VMASTLFIRTKMHRDTVEDGGAYMGALFFTVSVAMFNGILELHMTILKLPVFYKQRDLLF 453
+A T+++RT RD++ MG+LFF++ + +G+ EL +TI ++ VF KQ++L F
Sbjct: 523 FIAMTVYLRTGSTRDSLH-ANYLMGSLFFSLFKLLADGLPELTLTISRIAVFCKQKELYF 581
Query: 454 YPSWAYSLPPWILKIPITLLEVAIWEGISYYAIGYDPIFAR 494
YP+WAY++P ILKIPI+ LE +W ++YY IGY P R
Sbjct: 582 YPAWAYAIPSAILKIPISFLESFLWTMLTYYVIGYSPEMGR 622
Score = 86.3 bits (212), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 43/69 (62%), Positives = 51/69 (73%), Gaps = 2/69 (2%)
Query: 154 IKPDADVDASMKAAVLEGQQTSVVTDYILKILGLEVCADIMVGDGMIRGISGGQKKRVTT 213
I PD D+DA MKAA +EG +T++ TDYILKILGL +CAD VGD GISGGQK+R+TT
Sbjct: 263 IVPDPDIDAYMKAASIEGSKTNLQTDYILKILGLTICADTRVGDASRPGISGGQKRRLTT 322
Query: 214 DGHIVYQGP 222
IV GP
Sbjct: 323 GEMIV--GP 329
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 31/84 (36%), Positives = 55/84 (65%), Gaps = 6/84 (7%)
Query: 21 QQVKQVGLDIPTVEVRFENLNVEAQV-YVGARALPSLFKFFANVLEGFLYYLHIIRSPKN 79
+++ +VG+D+P +E RF +L VEA+ V + +P+L+ ++ L F+ +
Sbjct: 97 KRIDEVGIDLPKIEARFSDLFVEAECEVVYGKPIPTLWNAISSKLSRFM-----CSNQAK 151
Query: 80 QLHVLQNISGIIKPQRMTLLLGPP 103
++ +L+ +SGII+P+RMTLLLGPP
Sbjct: 152 KISILKGVSGIIRPKRMTLLLGPP 175